AMAN U BUZDAR to Etoposide
This is a "connection" page, showing publications AMAN U BUZDAR has written about Etoposide.
Connection Strength
0.077
-
Phase I-II study of high-dose etoposide in patients with refractory breast cancer. Invest New Drugs. 1991 Nov; 9(4):365-7.
Score: 0.021
-
Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer. Cancer. 1988 Nov 15; 62(10):2105-10.
Score: 0.017
-
Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years. Cancer. 2006 Jun 01; 106(11):2327-36.
Score: 0.014
-
Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol. 2001 Feb 01; 19(3):628-33.
Score: 0.010
-
Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support. Cancer. 1994 Apr 15; 73(8):2157-67.
Score: 0.006
-
A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer. J Clin Oncol. 1990 Nov; 8(11):1782-8.
Score: 0.005
-
Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support. J Clin Oncol. 1990 Jul; 8(7):1207-16.
Score: 0.005